S.M. KIM, N.V. KORSHUNOVA, E.M. GALKINA, I.V. PONOMAREVA

The Orenburg branch of the S. Fyodorov Eye Microsurgery Federal State Institution, 17 Salmyshskaya Str., Orenburg, Russian Federation, 460047 

Kim S.M. ― Head of the Department of Conservative Therapy, tel. (3532) 36-83-04, e-mail: svetlanakim74@mail.ru

Korshunova N.V. ― ophthalmologist of the Department of Conservative Therapy, tel. (3532) 36-83-04, e-mail: nauka@ofmntk.ru

Galkina E.M. ― physician of the Department of Conservative Therapy, tel. (3532) 36-34-13, e-mail: ofmntkmg@esoo.ru

Ponomareva I.V. ― Head of the Diagnostic Department, tel. (3532) 65-02-46, e-mail: ofmntkmg@esoo.ru

The purpose of the study is to investigate the effectiveness of an integrated approach in the treatment of partial optic nerve atrophy (PONA) of various origins using intravenous injections of Citicoline (Ceraxon) and Actovegin. We analyzed hospital records of 42 patients (73 eyes) aged 43-80 years. All patients were divided into two groups: main group ― 19 patients (34 eyes) and control group ― 23 (39 eyes). Subgroups by PONA etiology were allocated in each group. Patients of the main group received complex treatment in the form of parabulbar, underconjunctival, intramuscular injections with intravenous injections of Citicoline and Actovegin. Patients of the control group received the same treatment but without intravenous injections of Citicoline and Actovegin. The proposed integrated medical treatment with Citicoline and Actovegin allowed to increase and stabilize visual functions in 82% of patients with partial optic nerve atrophy.

Key words: Citicoline, Actovegin, partial optic nerve atrophy.

REFERENCES

1. Kamenskikh T.G. Eksperimental’no-klinicheskoe obosnovanie kompleksnoy terapii bol’nykh s chastichnoy atrofiey zritel’nogo nerva: avtoref. dis. … dokt. med. nauk [Experimentally-clinical substantiation of complex treatment of patients with partial atrophy of the optic nerve. Synopsis of dis. Dr med. sciences]. Samara, 2008. Pp. 4-6.
2. Libman E.S. Sostoyanie i dinamika slepoty i invalidnosti vsledstvie patologii organa zreniya v Rossii [State and dynamics of blindness and disability due to pathology of the vision in Russia]. 7-y S»ezd oftal’mologov Rossii. Moscow, 2000. Vol. 2. P. 219.
3. Nikiforov A.S. Neyrooftal’mologiya [Neuro]. Moscow, 2008. Pp. 228-230.
4. Egorov E.A., Astakhov Yu.S., Stavitskaya T.V. Oftal’mofarmakologiya. Rukovodstvo dlya vrachey. 2-e izdanie [Oftalmofarmakologiya. Guidelines for doctors. 2nd edition]. Moscow: GEOTAR-Media, 2005. Pp. 290-292.
5. Retinalamin. Neyroprotektsiya v oftal’mologii, pod red. I.B. Maksimova, V.V. Neroeva [Retinalamin. Neuroprotection in ophthalmology. Ed. by I.B. Maksimov, V.V. Neroeva]. Saint Petersburg: Nauka, 2007. 160 p.
6. Solomatin I.N. Primenenie preparata mildronata v oftal’mologii [Use of the drug in ophthalmology mildronata]. IV Konf. Oftal’mologov Pribaltiki, Riga, 1990. P. 98.
7. Linnik L.F. Nauchnye predposylki ispol’zovaniya fizicheskikh vozdeystviy pri lechenii chastichnoy atrofii zritel’nogo nerva [Scientific background use physical effects in the treatment of partial atrophy of the optic nerve]. VI S»ezd oftal’mologov Rossii: tezisy dokladov. Moscow, 1994. P. 96.
8. Linnik L.F., Shigina N.A., Kuman I.G et al. Treatment of partial atrophy of the optic nerve to the background magnetic stimulation by vascular insufficiency. Oftal’mokhirurgiya, 1992, no. 3, pp. 57-62 (in Russ.).
9. Linnik L.F., Antropov G.M., Boldysheva I.A. et al. Lechenie atrofii zritel’nogo nerva s primeneniem begushchego magnitnogo polya [Treatment of the atrophy of the optic nerve with a traveling magnetic field]. Aktual’nye problemy sovremennoy oftal’mologii: materialy Povolzhskoy nauchno-prakticheskoy konferentsii oftal’mologov. Saratov, 1996. P. 261.
10. Duginov A.G., Ioyleva E.E., Shatskikh A.V. et al. Treatment of the atrophy of the optic nerve with a traveling magnetic field. Oftal’mokhirurgiya, 2008, no. 5, pp. 24-28 (in Russ.).
11. Shavlovskaya O.A. Citicoline, new therapeutic options. Lechashchiy vrach, 2014, 10, p. 12 (in Russ.).
12. Morozova N.S. Vliyanie neyroprotektornoy terapii na faktory apoptoza pri glaukomatoznoy opticheskoy neyropatii: avtoref. dis. … kand. med. nauk [Effect of neuroprotective therapy on apoptosis factors for glaucomatous optic neuropathy. Synopsis of dis. PhD med. sciences]. Moscow, 2013. 24 p.
13. Firsov A.A., Smirnov A.A., Usanova T.A., Firsova S.V. Modern possibilities of prevention and treatment of vascular cognitive impairment. Arkhiv vnutrenney meditsiny, 2013, no. 3/11, pp. 1-6 (in Russ.).